On 11/6/24, OptimizeRX Corp (NASDAQ: OPRX) stock enjoyed a major increase of 19.8%, closing at $6.12. Moreover, trading volume in this advance was exceptionally high at 232% of normal. Relative to the market the stock has been extremely weak over the last nine months but has risen 10.9% during the last week.
Current PriceTarget Research Rating
With future capital returns forecasted to exceed the cost of capital, OPRX is expected to be a modest Value Builder.
OptimizeRX has a current Value Trend Rating of D (Negative). The Value Trend Rating reflects inconsistent signals from PTR’s two proprietary measures of a stock’s attractiveness. OptimizeRX has a neutral Appreciation Score of 50 but a poor Power Rating of 26, resulting in the Negative Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of D. This review will be completed in the next several days.
Be the first to comment